These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24275649)

  • 1. Locking intracellular helices 2 and 3 together inactivates human P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Jan; 289(1):229-36. PubMed ID: 24275649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human P-glycoprotein contains a greasy ball-and-socket joint at the second transmission interface.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2013 Jul; 288(28):20326-33. PubMed ID: 23733192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing mutations located throughout the human multidrug resistance P-glycoprotein disrupt interactions between the nucleotide binding domains.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2004 Sep; 279(37):38395-401. PubMed ID: 15247215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites.
    Loo TW; Clarke DM
    J Biol Chem; 2000 Jun; 275(26):19435-8. PubMed ID: 10806188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 2015 Jul; 290(27):16954-63. PubMed ID: 25987565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Jan; 278(3):1575-8. PubMed ID: 12421806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
    Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
    Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together.
    Loo TW; Bartlett MC; Detty MR; Clarke DM
    J Biol Chem; 2012 Aug; 287(32):26806-16. PubMed ID: 22700974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR).
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2008 Oct; 283(42):28190-7. PubMed ID: 18708637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Sep; 289(36):24749-58. PubMed ID: 25053414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Mar; 289(12):8484-92. PubMed ID: 24523403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attachment of a 'molecular spring' restores drug-stimulated ATPase activity to P-glycoprotein lacking both Q loop glutamines.
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2017 Jan; 483(1):366-370. PubMed ID: 28025146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "LSGGQ" motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2002 Nov; 277(44):41303-6. PubMed ID: 12226074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
    Loo TW; Clarke DM
    J Biol Chem; 1997 Aug; 272(34):20986-9. PubMed ID: 9261097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 2015 Dec; 290(49):29389-401. PubMed ID: 26507655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Oct; 278(41):39706-10. PubMed ID: 12909621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70.
    Kapoor K; Bhatnagar J; Chufan EE; Ambudkar SV
    J Biol Chem; 2013 Nov; 288(45):32622-32636. PubMed ID: 24064216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular model and ATPase activity of carboxyl-terminal nucleotide binding domain from human P-glycoprotein.
    Qian F; Wei D; Liu J; Yang S
    Biochemistry (Mosc); 2006; 71 Suppl 1():S18-24, 1-2. PubMed ID: 16487063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2002 Aug; 277(31):27585-8. PubMed ID: 12070134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.